https://www.neat-id.org/news-1/large-european-study-shows-dolutegravir-based-two-drug-regimens-maintain-viral-suppression-in-%3E98%25-of-people-with-hiv-over-96-weeks 2026-02-04 https://www.neat-id.org/news-1/the-neat-id-foundation-announces-publication-in-the-lancet-infectious-diseases-from-the-late-presenter-treatment-optimization-(laptop)-study---the-largest-randomized-clinical-trial-to-date-dedicated-to-identifying-optimal-first-line-antiretroviral-therapy-for-people-with-advanced-hiv-disease. 2025-11-28 https://www.neat-id.org/news-1/neat-id-publication-in-hiv-medicine%3A-new-study-highlights-key-risk-factors-for-severe-covid-19-in-people-living-with-hiv- 2025-11-05 https://www.neat-id.org/news-1/neat-id-foundation-marks-a-successful-presence-at-eacs-2025-in-paris 2025-11-04 https://www.neat-id.org/news-1/neat-id-rapid-oral-abstract-presentation-at-eacs-2025%3A-results-from-the-%E2%80%9Cmash-1%E2%80%9D-study.---mpox-related-hospitalization-higher-in-people-living-with-hiv%3A-european-mash-1-cohort-data-presented-at-eacs-2025- 2025-10-13 https://www.neat-id.org/news-1/neat-id-e-poster-presentation-at-eacs-2025%3A-results-from-the-%E2%80%9Cdrew%E2%80%9D-study 2025-10-13 https://www.neat-id.org/news-1/dr.-geoffroy-liegeon-awarded-neat-id-young-investigator-of-the-year-award-2025 2025-08-26 https://www.neat-id.org/news-1/poster-presentation-at-ias-2025%3A-results-from-the-%E2%80%9Cc2c%E2%80%9D-study 2025-07-10 https://www.neat-id.org/news-1/neat-id-publication-in-aids-july-2025-edition%3A-new-european-study-confirms-effectiveness-and-safety-of-doravirine-based-hiv-regimens-in-real-world-settings 2025-06-25 https://www.neat-id.org/news-1/poster-presentation-at-bhiva-2025%3A-results-from-the-fost-switch-study-on-fostemsavir-in-hiv-treatment 2025-04-23 https://www.neat-id.org/news-1/european-clinical-scientists-from-the-neat-id-network-present-late-presenter-treatment-optimisation-(laptop)-study-results-for-the-first-time-at-the-conference-on-retroviruses-and-opportunistic-infections-(croi)-2025-in-san-francisco.--the-laptop-study-is-the-first-fully-powered-head-to-head-trial-in-this-particularly-vulnerable-patient-group 2025-04-14 https://www.neat-id.org/news-1/neat-id%2C-the-european-treatment-network-of-hiv%2C-hepatitis-and-global-emerging-infectious-diseases-has-appointed-dr-esteban-martinez%2C-md%2C-as-president. 2025-04-14